Karyopharm Therapeutics (NASDAQ:KPTI) held a virtual special meeting of stockholders on Feb. 18, 2026, to vote on two proposals outlined in the company’s proxy materials. The meeting was chaired by ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results